Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker
Authors:
- Anna PacelliAPAnna Pacelli
- Patrick RochePRPatrick Roche
- Harry G. RittenhouseHRHarry G. Rittenhouse
- Robert L. WolfertRWRobert L. Wolfert
- Charles Y.F. YoungCYCharles Y.F. Young
- George G. KleeGKGeorge G. Klee
- Donald J. TindallDTDonald J. Tindall
- David G. BostwickDBDavid G. Bostwick
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Molecular biology of prostatic intraepithelial neoplasiaThe Prostate, 1996
- Prostatic adenocarcinoma labelled with a monoclonal antibody and polyclonal serum: a quantitative assessmentBritish Journal of Urology, 1996
- Dual monoclonal antibody immunoassay for free prostate-specific antigenThe Prostate, 1996
- Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new eraUrology, 1995
- Structure, function, and regulation of the enzyme activity of prostate-specific antigenWorld Journal of Urology, 1993
- Androgen induction of a human prostate-specific kallikrein, hKLK2: Characterization of an androgen response element in the 5' promoter region of the geneBiochemistry, 1993
- Tissue-specific and hormonal regulations of human prostate-specific glandular kallikreinBiochemistry, 1992
- Silver-Stained Structures in Prostatic Carcinoma: Evaluation of Diagnostic and Prognostic Relevance by Automated Image AnalysisUrologia Internationalis, 1991
- Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinomaThe Prostate, 1991
- High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate‐specific antigenFEBS Letters, 1988